Dorra Pharma will attend DCAT week 2025 in New York City, taking place from 17th to 21st March. Roger Laforce, Managing Director of Dorra Europe, the first overseas office of Dorra Pharma, and Alessandro Gagnoni, Director Operations, Dorra Europe, shall represent Dorra during one of the best trade events in the pharma and chemical industry.
Founded in 2011 by Judy Zhu, Dorra has become a reliable supplier of many CDMOs and pharma companies globally offering products and services in
- CDMO for exclusive projects for key starting materials and intermediates
- Supply Chain Services with our 3’000+ network of manufacturers in China
- In-licensing of Drug Product for unmet medical needs and niche indications for the Chinese market
At our own R&D sites based in Taizhou and Nanjing, we develop processes in-house using automated plants and AI for route scouting and data analysis and transfer the processes to our 3 sites both for GMP and non-GMP materials, offering over 3’500 m3 of manufacturing capacity in these sites.
With our year-long experience in CDMO and Supply Chain Management for our clients, we understand ourselves as customer focused and technology driven team. Our innovation is focusing on flow- and continuous processes, process automation and biocatalysis using AI for protein engineering.
Our well filled agenda for DCAT week will see meetings at our suite at the Hyatt Grand Central Station or at the suites of our clients and contacts. Get in touch with us under rlaforce@dorrapharma.com and alessandro@dorrapharma.com!
